Cargando…
Neutrophils protect lymphoma cells against cytotoxic and targeted therapies through CD11b/ICAM-1 binding
Innate immune cells constitute a substantial proportion of the cells within the tumor microenvironment. Besides the contribution of the microenvironment to tumor proliferation and survival, there is direct evidence that interactions between tumor cells and their microenvironment alter sensitivity to...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641171/ https://www.ncbi.nlm.nih.gov/pubmed/29069828 http://dx.doi.org/10.18632/oncotarget.20350 |
_version_ | 1783271176175353856 |
---|---|
author | Hirz, Taghreed Matera, Eva-Laure Chettab, Kamel Jordheim, Lars Petter Mathé, Doriane Evesque, Anne Esmenjaud, Justine Salles, Gilles Dumontet, Charles |
author_facet | Hirz, Taghreed Matera, Eva-Laure Chettab, Kamel Jordheim, Lars Petter Mathé, Doriane Evesque, Anne Esmenjaud, Justine Salles, Gilles Dumontet, Charles |
author_sort | Hirz, Taghreed |
collection | PubMed |
description | Innate immune cells constitute a substantial proportion of the cells within the tumor microenvironment. Besides the contribution of the microenvironment to tumor proliferation and survival, there is direct evidence that interactions between tumor cells and their microenvironment alter sensitivity to anti-cancer agents. Neutrophils, a key player in the innate immune system, have been less studied than many other immune cells regarding their impact on cancer cell response to anti-cancer agents. In our 2D and 3D coculture systems, human neutrophils and differentiated HL60 cells attenuated the sensitivity of various lymphoma cell lines to several anti-cancer agents, including targeted therapies. Neutrophil-induced protection was dependent on cell-cell interaction between CD11b and ICAM-1 expressed by neutrophils and B cells, respectively and was shown to be Mcl-1-dependent. The protective effect of neutrophils was validated in vivo using immune-compromised mice inoculated with human NHL with our without neutrophils then followed by treatment with chemotherapy. Similar findings were made on primary cells purified from patients with chronic lymphocytic leukemia, treated with fludarabine or targeted agents in the presence of autologous neutrophils. In a clinical study, patients with non-Hodgkin's lymphoma with increased neutrophil counts displayed a reduced response rate to therapy. These findings reveal a novel protective mechanism of neoplastic B cells involving innate immune cells which could be pharmacologically targeted to enhance the antitumor effect of therapy. |
format | Online Article Text |
id | pubmed-5641171 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-56411712017-10-24 Neutrophils protect lymphoma cells against cytotoxic and targeted therapies through CD11b/ICAM-1 binding Hirz, Taghreed Matera, Eva-Laure Chettab, Kamel Jordheim, Lars Petter Mathé, Doriane Evesque, Anne Esmenjaud, Justine Salles, Gilles Dumontet, Charles Oncotarget Research Paper Innate immune cells constitute a substantial proportion of the cells within the tumor microenvironment. Besides the contribution of the microenvironment to tumor proliferation and survival, there is direct evidence that interactions between tumor cells and their microenvironment alter sensitivity to anti-cancer agents. Neutrophils, a key player in the innate immune system, have been less studied than many other immune cells regarding their impact on cancer cell response to anti-cancer agents. In our 2D and 3D coculture systems, human neutrophils and differentiated HL60 cells attenuated the sensitivity of various lymphoma cell lines to several anti-cancer agents, including targeted therapies. Neutrophil-induced protection was dependent on cell-cell interaction between CD11b and ICAM-1 expressed by neutrophils and B cells, respectively and was shown to be Mcl-1-dependent. The protective effect of neutrophils was validated in vivo using immune-compromised mice inoculated with human NHL with our without neutrophils then followed by treatment with chemotherapy. Similar findings were made on primary cells purified from patients with chronic lymphocytic leukemia, treated with fludarabine or targeted agents in the presence of autologous neutrophils. In a clinical study, patients with non-Hodgkin's lymphoma with increased neutrophil counts displayed a reduced response rate to therapy. These findings reveal a novel protective mechanism of neoplastic B cells involving innate immune cells which could be pharmacologically targeted to enhance the antitumor effect of therapy. Impact Journals LLC 2017-08-18 /pmc/articles/PMC5641171/ /pubmed/29069828 http://dx.doi.org/10.18632/oncotarget.20350 Text en Copyright: © 2017 Hirz et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Research Paper Hirz, Taghreed Matera, Eva-Laure Chettab, Kamel Jordheim, Lars Petter Mathé, Doriane Evesque, Anne Esmenjaud, Justine Salles, Gilles Dumontet, Charles Neutrophils protect lymphoma cells against cytotoxic and targeted therapies through CD11b/ICAM-1 binding |
title | Neutrophils protect lymphoma cells against cytotoxic and targeted therapies through CD11b/ICAM-1 binding |
title_full | Neutrophils protect lymphoma cells against cytotoxic and targeted therapies through CD11b/ICAM-1 binding |
title_fullStr | Neutrophils protect lymphoma cells against cytotoxic and targeted therapies through CD11b/ICAM-1 binding |
title_full_unstemmed | Neutrophils protect lymphoma cells against cytotoxic and targeted therapies through CD11b/ICAM-1 binding |
title_short | Neutrophils protect lymphoma cells against cytotoxic and targeted therapies through CD11b/ICAM-1 binding |
title_sort | neutrophils protect lymphoma cells against cytotoxic and targeted therapies through cd11b/icam-1 binding |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641171/ https://www.ncbi.nlm.nih.gov/pubmed/29069828 http://dx.doi.org/10.18632/oncotarget.20350 |
work_keys_str_mv | AT hirztaghreed neutrophilsprotectlymphomacellsagainstcytotoxicandtargetedtherapiesthroughcd11bicam1binding AT materaevalaure neutrophilsprotectlymphomacellsagainstcytotoxicandtargetedtherapiesthroughcd11bicam1binding AT chettabkamel neutrophilsprotectlymphomacellsagainstcytotoxicandtargetedtherapiesthroughcd11bicam1binding AT jordheimlarspetter neutrophilsprotectlymphomacellsagainstcytotoxicandtargetedtherapiesthroughcd11bicam1binding AT mathedoriane neutrophilsprotectlymphomacellsagainstcytotoxicandtargetedtherapiesthroughcd11bicam1binding AT evesqueanne neutrophilsprotectlymphomacellsagainstcytotoxicandtargetedtherapiesthroughcd11bicam1binding AT esmenjaudjustine neutrophilsprotectlymphomacellsagainstcytotoxicandtargetedtherapiesthroughcd11bicam1binding AT sallesgilles neutrophilsprotectlymphomacellsagainstcytotoxicandtargetedtherapiesthroughcd11bicam1binding AT dumontetcharles neutrophilsprotectlymphomacellsagainstcytotoxicandtargetedtherapiesthroughcd11bicam1binding |